Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing vaccines to counter bioterrorist threats.

Daniel M Altmann1

  • 1Department of Infectious Diseases, Imperial College, Hammersmith Hospital, London, W12 0NN, UK. d.altmann@ic.ac.uk

Expert Review of Vaccines
|July 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID.

Communications medicine·2026
Same author

How to respond when biomedical science and global health is under existential threat.

Nature reviews. Immunology·2025
Same author

Differences in Cytokine Expression at Baseline and in Response to Mineral Stimulation by Peripheral Blood Mononuclear Cells from Podoconiosis Cases and Healthy Control Individuals.

Tropical medicine and infectious disease·2024
Same author

Protective immunity to repeated COVID-19 breakthrough infections.

Clinical immunology (Orlando, Fla.)·2024
Same author

Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosis.

Nature communications·2024
Same author

Arming up against Omicron subvariants.

Cell host & microbe·2024
Same journal

Projected health and economic impact of PCV20 vaccination in UK children: a dynamic transmission model.

Expert review of vaccines·2026
Same journal

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Whole cell and acellular pertussis vaccines - rethinking the evidence.

Expert review of vaccines·2026
Same journal

Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic.

Expert review of vaccines·2026
Same journal

Narrative shielding and prebunking: a synergistic strategy against vaccine hesitancy in pediatrics.

Expert review of vaccines·2026
See all related articles

Innovative vaccine research targets bioterrorism threats, but faces novel challenges. Defining immune parameters for these advanced vaccines requires addressing previously unencountered vaccinology predicaments.

Area of Science:

  • Biodefense research
  • Vaccine immunology
  • Pathogen threat assessment

Background:

  • Extensive research programs are defining immune parameters for vaccines against bioterrorism pathogens.
  • Existing vaccinology frameworks may not adequately address novel vaccine development challenges.

Purpose of the Study:

  • To highlight the unique challenges in developing vaccines against bioterrorism threats.
  • To identify predicaments in vaccine development and utilization not previously considered in vaccinology.

Main Methods:

  • Review of current research programs in biodefense vaccines.
  • Analysis of potential challenges in the application of novel vaccine technologies.

Main Results:

  • Significant research efforts are focused on immune parameters for bioterrorism vaccines.

Related Experiment Videos

  • The development and deployment of these vaccines present unprecedented issues.
  • Conclusions:

    • Novel approaches are needed to overcome the unique challenges in bioterrorism vaccine development.
    • The field of vaccinology must address new predicaments to ensure effective biodefense strategies.